Our Strategy and Objectives

We strive to promote the advancement of personalized medicine and individualized immune therapies for more effective diagnosis and treatment of serious diseases such as cancer, resulting in long-term benefits for all healthcare stakeholders (patients, payers, providers and manufacturers). We want to achieve this by facilitating innovative solutions in the healthcare sector through regional, national and European collaborations. Bundling the outstanding expertise in the Rhine-Main region in individualized medicine and establishing the region as a global leader in the field is central to our strategy.

Our Projects

We play a leading role in different projects at the national and European level. Our projects aim at fostering innovations in the healthcare sector
  • strengthening collaboration between academia, small and medium-sized enterprises and large corporations
  • boosting the digital transformation and adaptation of current technologies, such as Artificial Intelligence, in small and medium-sized enterprises
  • increasing information about and acceptance of personalized medicine and individualized immunotherapies among the general public

 The “Digital Enterprise Innovations for Bioimaging, Biosensing and Biobanking Industries” project aims at promoting disruptive innovations in the medical diagnostic value chain by applying current digital technologies such as Artificial Intelligence.

Read More…

The goal of the “Health Axis Europe Partnering” project is to  facilitate international knowledge exchange between academia as well as small and medium-sized enterprises as innovators on the one side and global healthcare companies as innovation seekers on the other side.

Read More…

The “Personalized Medicine Innovation through Digital Enterprise Solutions” project aims at providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology.

Read More…

The German Federal Ministry of Education and Research (BMBF) and other project partners have joined forces to promote cancer research. Many stakeholders are involved in this 10-year program.

Read More…